Sort   by:  
 Page size 
UnknownHalogenated 3-Nitro-2<i>H</i>-Chromenes as Potential Agents Against Multidrug-Resistant Bacteria.
Not available
S-EPMC11939745 | biostudies-literature
ProteomicsSynapse-centered novel omics targets in Alzheimer’s disease
Synapse dysfunction is an early event of Alzheimer’s disease (AD). It is caused by multiple cellular and pathological factors such as Amyloid beta, p-tau, inflammation, and aging. However, the exact molecular mechanism of synapse dysfunction in AD is largely unknown. Therefore, to understand the mol...
ORGANISM(S): Homo sapiens (Human) 
2025-10-27 | PXD055784 | Pride
Proteomics Synaptosome Alzheimer's 
UnknownBifunctional nickel-iminodiacetic acid-core-shell silica nanoparticles for the exclusion of high molecular weight proteins and purification of His-tagged recombinant proteins.
Not available
S-EPMC9063014 | biostudies-literature
TranscriptomicsEfficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
Primary effusion lymphoma is an aggressive B-cell lymphoma most commonly diagnosed in HIV-positive patients and universally associated with Kaposi’s sarcoma-associated herpesvirus (KSHV). Chemotherapy treatment of PEL yields only short-term remissions in the vast majority of patients yet efforts to ...
ORGANISM(S): Mus musculus 
2010-07-20 | E-GEOD-22594 | biostudies-arrayexpress
UnknownGenotype, but Not Climate, Affects the Resistance of Honey Bees (Apis mellifera) to Viral Infections and to the Mite Varroa destructor.
Not available
S-EPMC9320602 | biostudies-literature
UnknownVolatile Metabolome and Transcriptomic Analysis of <i>Kosakonia cowanii</i> Ch1 During Competitive Interaction with <i>Sclerotium rolfsii</i> Reveals New Biocontrol Insights.
Not available
S-EPMC12300148 | biostudies-literature
UnknownTert-butyl-(4-hydroxy-3-((3-(2-methylpiperidin-yl)propyl)carbamoyl)phenyl)carbamate Has Moderated Protective Activity in Astrocytes Stimulated with Amyloid Beta 1-42 and in a Scopolamine Model.
Not available
S-EPMC7672627 | biostudies-literature
ProteomicsMulti-omics characterization of response to PD-1 inhibitors in advanced melanoma
Immunotherapy improves the survival of patients with advanced melanoma, 40% of whom become long-term responders. However, not all patients respond to immunotherapy. Further knowledge about the processes involved in response and resistance to immunotherapy is still needed. In this study, clinical par...
ORGANISM(S): Homo sapiens (Human) 
2023-09-25 | PXD038155 | Pride
Omics Ffpe Immunotherapy Pd-1 inhibitor Melanoma 
UnknownSildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial.
Not available
S-EPMC8721481 | biostudies-literature
UnknownEffect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial.
Not available
S-EPMC9073661 | biostudies-literature
Sort   by:  
 Page size